While some patients with disruptive behavior continue to have difficulty adjusting to the therapeutic approaches, most youths with disruptive behavior are able to make significant progress. There is a trend, though, for youths with disruptive behavior to require the most time and to use the various types of services more often than their non-disruptive-behaved counterparts.
Children with BD may show signs of oppositional and rule-breaking personalities that manifest in conduct problems when a diagnosis of BD is considered. These signs may be difficult to recognize because of the comorbidity common to the BD and oppositional defiant disorder (ODD). Data from a recent study, the comorbidity was most evident with the comorbidity between the BD and ODD. In conclusion, clinical presentation of children with the comorbid ODD and BD could be helpful for evaluating the co-occurrences of these conditions.
The authors conclude that disruptive behavior disorder is a behavioral disturbance with a complex etiology that can occur in both the child and the adolescent.
Despite the lack of a single cause, there is strong evidence for a complex etiology, and there seems little agreement on specific risk factors, partly because of the interrelationships between all such factors. The cause most likely to be identified is a risk factor or set of factors that act during early development.
Over 1,000,000 people in the United States are affected by a disruptive behavior disorder at any given point in time. This disorder is associated with functional impairment and poor social adjustment, and thus poses a major public health challenge to society.
In a recent study, findings suggest that there may be some aspects of behavior disorder that are not affected by drug therapy. However, this study does not prove or disproof that all aspects of behavior disorder are responsive to intervention with the drug milnacipran. Clinicians, in summary, should be cautious until more evidence is collected. They may think of patients with behavior disorder as one who cannot be cured and not seek to intervene with behavior therapy.
The CBHN intervention model is safe, feasible, and accepted by patients and providers. Furthermore, as the CBHN model of care for pediatric psychiatric inpatient care increased, the time spent at the CBHN station decreased among adult admissions. This was not related to changes in children's behavioral health outcomes.
At least in DSM-IV-TR-defined families, there was no evidence of an increased incidence of disruptive behavior disorder. Therefore, it seems that not all disrupted families exhibit problems of disruptive behavior. The familial risk for disruptive behavior disorder in the present study was 0%.
The overwhelming majority of callers to CBHNs reported at least one medication-related adverse event. Most callers reported moderate or severe problems with at least one commonly prescribed medication (i.e., antidepressants, antihypertensives, mood stabilizers, sedatives, or steroids). Callers reported more severe, longer-term adverse effects of mood stabilizers (28.3% vs. 22.3%), antidepressants (29.0% vs. 20.4%), and sedatives (41.7% vs. 28.7%) than callers to an HCP. In addition, callers reported more severe, longer-term adverse effects of mood stabilizers (26.8%) and antidepressants (27.
There are limited reports in peer-reviewed journals of trials using CBHNs, most of which used CBHNs as facilitators or coordinators with the majority focusing on children with disruptive behavior issues. However, we describe the potential role of CBHNs in a behavioral health navigation.
This research indicates that disruptive behavior disorder (DBD) is a biological error. Bipolar disorder, schizophrenia, and psychosis are all related to higher rates of DBD. It is important to remember that DBD is not simply a reaction to stressful life events, but rather, is a biological error. While it is possible for BPD and schizophrenia to co-occur, the two are not the same.
Child behavior, with CBHNav, is similar to adult behavior and is different from previous work regarding child behavior. This work highlights the importance of developing [child behavior assessment (CBA) training to provide CBHNav to pediatricians.